72 related articles for article (PubMed ID: 18242509)
1. Deathproof: new insights on the role of skp2 in tumorigenesis.
Reed SI
Cancer Cell; 2008 Feb; 13(2):88-9. PubMed ID: 18242509
[TBL] [Abstract][Full Text] [Related]
2. Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence.
Lin HK; Chen Z; Wang G; Nardella C; Lee SW; Chan CH; Yang WL; Wang J; Egia A; Nakayama KI; Cordon-Cardo C; Teruya-Feldstein J; Pandolfi PP
Nature; 2010 Mar; 464(7287):374-9. PubMed ID: 20237562
[TBL] [Abstract][Full Text] [Related]
3. Skp2 suppresses p53-dependent apoptosis by inhibiting p300.
Kitagawa M; Lee SH; McCormick F
Mol Cell; 2008 Feb; 29(2):217-31. PubMed ID: 18243116
[TBL] [Abstract][Full Text] [Related]
4. A Chemical Inhibitor of the Skp2/p300 Interaction that Promotes p53-Mediated Apoptosis.
Oh M; Lee JH; Moon H; Hyun YJ; Lim HS
Angew Chem Int Ed Engl; 2016 Jan; 55(2):602-6. PubMed ID: 26593157
[TBL] [Abstract][Full Text] [Related]
5. Skp2 Inhibitors: Novel Anticancer Strategies.
Lee Y; Lim HS
Curr Med Chem; 2016; 23(22):2363-79. PubMed ID: 27160538
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of the Cks1-dependent recognition of p27(Kip1) by the SCF(Skp2) ubiquitin ligase.
Hao B; Zheng N; Schulman BA; Wu G; Miller JJ; Pagano M; Pavletich NP
Mol Cell; 2005 Oct; 20(1):9-19. PubMed ID: 16209941
[TBL] [Abstract][Full Text] [Related]
7. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.
Uddin S; Ahmed M; Bavi P; El-Sayed R; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Hussain AR; Al-Kuraya KS
Cancer Res; 2008 May; 68(9):3379-88. PubMed ID: 18451165
[TBL] [Abstract][Full Text] [Related]
8. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
Bashir T; Dorrello NV; Amador V; Guardavaccaro D; Pagano M
Nature; 2004 Mar; 428(6979):190-3. PubMed ID: 15014502
[TBL] [Abstract][Full Text] [Related]
9. Regulation of neddylation and deneddylation of cullin1 in SCFSkp2 ubiquitin ligase by F-box protein and substrate.
Bornstein G; Ganoth D; Hershko A
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11515-20. PubMed ID: 16861300
[TBL] [Abstract][Full Text] [Related]
10. Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation.
Huang H; Regan KM; Wang F; Wang D; Smith DI; van Deursen JM; Tindall DJ
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1649-54. PubMed ID: 15668399
[TBL] [Abstract][Full Text] [Related]
11. Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation.
Wu YJ; Bond M; Sala-Newby GB; Newby AC
Circ Res; 2006 May; 98(9):1141-50. PubMed ID: 16574903
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB.
Lin HK; Wang G; Chen Z; Teruya-Feldstein J; Liu Y; Chan CH; Yang WL; Erdjument-Bromage H; Nakayama KI; Nimer S; Tempst P; Pandolfi PP
Nat Cell Biol; 2009 Apr; 11(4):420-32. PubMed ID: 19270694
[TBL] [Abstract][Full Text] [Related]
13. Skp2 is over-expressed in breast cancer and promotes breast cancer cell proliferation.
Zhang W; Cao L; Sun Z; Xu J; Tang L; Chen W; Luo J; Yang F; Wang Y; Guan X
Cell Cycle; 2016 May; 15(10):1344-51. PubMed ID: 27111245
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Skp2 expression and activity and its role in cancer progression.
Chan CH; Lee SW; Wang J; Lin HK
ScientificWorldJournal; 2010 Jun; 10():1001-15. PubMed ID: 20526532
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of S-phase kinase associated protein 2 (Skp2) induces apoptosis in oral cancer cells.
Harada K; Supriatno ; Kawashima Y; Itashiki Y; Yoshida H; Sato M
Oral Oncol; 2005 Jul; 41(6):623-30. PubMed ID: 16050017
[TBL] [Abstract][Full Text] [Related]
16. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex.
Wei W; Ayad NG; Wan Y; Zhang GJ; Kirschner MW; Kaelin WG
Nature; 2004 Mar; 428(6979):194-8. PubMed ID: 15014503
[TBL] [Abstract][Full Text] [Related]
17. Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45(SKP2): evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway.
Lisztwan J; Marti A; Sutterlüty H; Gstaiger M; Wirbelauer C; Krek W
EMBO J; 1998 Jan; 17(2):368-83. PubMed ID: 9430629
[TBL] [Abstract][Full Text] [Related]
18. Cul4A and DDB1 associate with Skp2 to target p27Kip1 for proteolysis involving the COP9 signalosome.
Bondar T; Kalinina A; Khair L; Kopanja D; Nag A; Bagchi S; Raychaudhuri P
Mol Cell Biol; 2006 Apr; 26(7):2531-9. PubMed ID: 16537899
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated expression of SKP2 and its role in hematological malignancies.
Kulinski M; Achkar IW; Haris M; Dermime S; Mohammad RM; Uddin S
Leuk Lymphoma; 2018 May; 59(5):1051-1063. PubMed ID: 28797197
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral E1A targets Mdm4 to stabilize tumor suppressor p53.
Li Z; Day CP; Yang JY; Tsai WB; Lozano G; Shih HM; Hung MC
Cancer Res; 2004 Dec; 64(24):9080-5. PubMed ID: 15604276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
